Equillium Inc.(EQ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EQ Equillium Inc.

Market Closed 10-09 16:00:00 EDT

1.41

-0.03

-2.08%

盘后1.45

+0.04+2.84%

19:30 EDT

High1.46	Low1.38	Vol522.00K
Open1.45	D1 Closing1.44	Amplitude5.56%
Mkt Cap89.15M	Tradable Cap52.17M	Total Shares63.23M
T/O744.55K	T/O Rate1.41%	Tradable Shares37.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EQ","market":"US","secType":"STK","nameCN":"Equillium Inc.","latestPrice":1.41,"timestamp":1791576000000,"preClose":1.44,"halted":0,"volume":521997,"hourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.41,"latestTime":"19:30 EDT","volume":1804,"amount":2611.72,"timestamp":1791588605716,"change":0.04,"changeRate":0.028369,"amplitude":0.028369},"delay":0,"changeRate":-0.020833333333333353,"floatShares":36997100,"shares":63226556,"eps":-0.196776,"marketStatus":"Market Closed","change":-0.03,"latestTime":"10-09 16:00:00 EDT","open":1.45,"high":1.46,"low":1.38,"amount":744548.5417607999,"amplitude":0.055556,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.196776,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1539316800000,"exchange":"NASDAQ","adjPreClose":1.44,"postHourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.41,"latestTime":"19:30 EDT","volume":1804,"amount":2611.72,"timestamp":1791588605716,"change":0.04,"changeRate":0.028369,"amplitude":0.028369},"volumeRatio":0.8385814587620691,"impliedVol":1.7695,"impliedVolPercentile":0.8327},"requestUrl":"/m/hq/s/EQ/tweets","defaultTab":"tweets","newsList":[{"id":"2673961063","title":"Equillium Posts New Preclinical EQ504 Data Supporting Ulcerative Colitis Potential at La Jolla Immunology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2673961063","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673961063?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:07","pubTimestamp":1791317243,"startTime":"0","endTime":"0","summary":"Equillium posts new preclinical EQ504 data supporting ulcerative colitis potential at La Jolla Immunology ConferenceEquillium disclosed new preclinical findings for EQ504, an ulcerative colitis progra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL4wn4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","SG9999014039.USD","LU2210150020.SGD","EQ","SG9999014021.USD","IE00BN0W2V16.EUR","BK4139","IE00BKPKM429.USD","SG9999014005.SGD","BK4568","IE00BQXX3C00.GBP","LU0314104364.USD","SG9999014013.SGD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","BK4585","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673031008","title":"Roth MKM Sticks to Its Buy Rating for Equillium (EQ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673031008","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673031008?lang=en_us&edition=fundamental","pubTime":"2026-10-06 14:55","pubTimestamp":1791269737,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Adam Walsh reiterated a Buy rating on Equillium yesterday and set a price target of $12.00. The company’s shares closed yesterday ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-sticks-to-its-buy-rating-for-equillium-eq-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-sticks-to-its-buy-rating-for-equillium-eq-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081295","title":"Equillium Wins Australian Regulatory Clearance for EQ504 Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081295","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081295?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:06","pubTimestamp":1791230773,"startTime":"0","endTime":"0","summary":"Equillium wins Australian regulatory clearance for EQ504 Phase 1 trialEquillium secured Australian TGA clearance under the CTN scheme to start a first-in-human Phase 1 trial of EQ504.HREC approval rec","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL38Vpw4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BN0W2V16.EUR","BCDF","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014013.SGD","BK4568","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","EQ","BK4585","BK4139","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4588","SG9999014039.USD","LU2210150020.SGD","NDAQ","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014021.USD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081474","title":"Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081474?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:05","pubTimestamp":1791230700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA98H4T4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","EQ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081268","title":"Equillium - Expects to Begin Dosing by Early November 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081268?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:05","pubTimestamp":1791230700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA98H4T4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4139","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081219","title":"Equillium - Topline Phase 1 Data Expected Six Months After Study Initiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081219?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:05","pubTimestamp":1791230700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA98H4T4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671242122","title":"Equillium Posts New Preclinical EQ504 Data in Ulcerative Colitis at International AHR Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2671242122","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671242122?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:05","pubTimestamp":1790712357,"startTime":"0","endTime":"0","summary":"Equillium posts new preclinical EQ504 data in ulcerative colitis at International AHR ConferenceEquillium disclosed new preclinical findings for EQ504 in ulcerative colitis ahead of two poster present","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLJ3Xqr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4588","NDAQ","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BCDF","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014005.SGD","BK4112","BK4585","BK4568","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014021.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","EQ","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665135577","title":"Equillium Price Target Maintained with a $12.00/Share by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2665135577","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665135577?lang=en_us&edition=fundamental","pubTime":"2026-09-05 01:57","pubTimestamp":1788544620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EQ/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQ","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664653809","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664653809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664653809?lang=en_us&edition=fundamental","pubTime":"2026-09-04 03:30","pubTimestamp":1788463815,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Equillium (EQ) and Jade Biosciences (JBIO) with bull...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-326?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-326?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","LU0029874061.USD","XBI","BK4588","LU0128526141.USD","BK4539","XLV","BK4137","HCSG","JBIO","BK4568","EQ","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664114718","title":"Equillium to Join Cantor Global Healthcare Conference 2026 Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664114718","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664114718?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:32","pubTimestamp":1788352340,"startTime":"0","endTime":"0","summary":"Equillium to join Cantor Global Healthcare Conference 2026 fireside chatEquillium will join the Cantor Global Healthcare Conference on September 9, 2026, featuring a fireside chat at 9:45 a.m. EDT.Man","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL82vS7l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","IE00BKPKM429.USD","LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014039.USD","SG9999014005.SGD","BK4585","BK4588","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014021.USD","NDAQ","LU2095319765.USD","BK4568","IE00BN0W2W23.USD","BCDF","BK4139","EQ","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","BK4112","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662218687","title":"EQ Resources Names New Director, Reports No Share Interests","url":"https://stock-news.laohu8.com/highlight/detail?id=2662218687","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662218687?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:18","pubTimestamp":1787793489,"startTime":"0","endTime":"0","summary":"The latest update is out from EQ Resources Limited ( ($AU:EQR) ). EQ Resources Limited has appointed Nicole Anne Brook as a director effective 25 A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-names-new-director-reports-no-share-interests?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-names-new-director-reports-no-share-interests?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","EQ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662072186","title":"EQ Resources Names New Director and Discloses Equity Interests","url":"https://stock-news.laohu8.com/highlight/detail?id=2662072186","media":"TIPRANKS","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662072186?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:18","pubTimestamp":1787793481,"startTime":"0","endTime":"0","summary":"EQ Resources Limited ( ($AU:EQR) ) has issued an announcement. EQ Resources Limited has appointed Constandinos Dermedgoglou as a director effective...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-names-new-director-and-discloses-equity-interests?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-names-new-director-and-discloses-equity-interests?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4568","REZ","BK4215","EQR","BK4585","EQ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662201097","title":"EQ Resources overhauls board as it gears up for U.S. listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662201097","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662201097?lang=en_us&edition=fundamental","pubTime":"2026-08-25 07:03","pubTimestamp":1787612590,"startTime":"0","endTime":"0","summary":"EQ Resources Limited ( ($AU:EQR) ) has issued an update. EQ Resources has strengthened its board as it positions itself as an emerging mid-tier min...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-overhauls-board-as-it-gears-up-for-u-s-listing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-overhauls-board-as-it-gears-up-for-u-s-listing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661308662","title":"EQ Works Posts 40% Sequential Revenue Jump on Record ClearLake Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661308662","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661308662?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:42","pubTimestamp":1787262124,"startTime":"0","endTime":"0","summary":"EQ Inc ( ($TSE:EQ) ) has provided an update. EQ Works reported second-quarter 2026 revenue of $2.6 million, a 40% sequential increase supported by ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-works-posts-40-sequential-revenue-jump-on-record-clearlake-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-works-posts-40-sequential-revenue-jump-on-record-clearlake-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660474366","title":"EQ Resources Seeks ASX Quotation for Additional Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660474366","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660474366?lang=en_us&edition=fundamental","pubTime":"2026-08-20 08:32","pubTimestamp":1787185921,"startTime":"0","endTime":"0","summary":"EQ Resources Limited ( ($AU:EQR) ) just unveiled an update. EQ Resources Limited has applied for quotation on the ASX of 686,225 new ordinary fully...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-seeks-asx-quotation-for-additional-ordinary-shares-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-seeks-asx-quotation-for-additional-ordinary-shares-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQ","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659144803","title":"Equillium (EQ) Gets a Buy from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2659144803","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659144803?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:55","pubTimestamp":1786712147,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Steven Seedhouse maintained a Buy rating on Equillium today and set a price target of $10.00. Seedhouse covers the Health...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/equillium-eq-gets-a-buy-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/equillium-eq-gets-a-buy-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQ","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659194260","title":"Analysts Are Bullish on These Healthcare Stocks: PolyPid (PYPD), Equillium (EQ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659194260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659194260?lang=en_us&edition=fundamental","pubTime":"2026-08-14 10:30","pubTimestamp":1786674606,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PolyPid (PYPD) and Equillium (EQ) with bullish senti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-polypid-pypd-equillium-eq-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-polypid-pypd-equillium-eq-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PYPD","EQ","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659199804","title":"Positive Report for EQ Resources Limited (EQR) from Morgans","url":"https://stock-news.laohu8.com/highlight/detail?id=2659199804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659199804?lang=en_us&edition=fundamental","pubTime":"2026-08-14 08:35","pubTimestamp":1786667751,"startTime":"0","endTime":"0","summary":"Morgans analyst upgraded EQ Resources Limited to a Buy today and set a price target of A$0.52. In a report released on July 28, Canaccord Genuity a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-eq-resources-limited-eqr-from-morgans-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-eq-resources-limited-eqr-from-morgans-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4215","REZ","EQR","BK4585","EQ","BK4139","VMRK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659607571","title":"Equillium Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659607571","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659607571?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:02","pubTimestamp":1786654928,"startTime":"0","endTime":"0","summary":"Equillium Inc reports results for the quarter ended June 30 - Earnings SummaryEquillium IncEQ.OQreported a quarterly adjusted loss of 4 cents per share for the quarter ended June 30, higher than the s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL8N44A28I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659468167","title":"Equillium Q2 EPS $(0.04) Beats $(0.05) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659468167","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659468167?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:30","pubTimestamp":1786653033,"startTime":"0","endTime":"0","summary":"Equillium Q2 EPS $(0.04) Beats $(0.05) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/EQ","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Equillium Q2 EPS $(0.04) Beats $(0.05) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.equilliumbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.4492},{"period":"3month","weight":-0.5155},{"period":"6month","weight":-0.2167},{"period":"1year","weight":-0.0208},{"period":"ytd","weight":-0.0903}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.0313},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1417}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. Equillium, Inc. was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. The company was incorporated in 2017 and is headquartered in La Jolla, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.054449},{"month":2,"riseRate":0.625,"avgChangeRate":0.322617},{"month":3,"riseRate":0.375,"avgChangeRate":-0.15431},{"month":4,"riseRate":0.375,"avgChangeRate":-0.117774},{"month":5,"riseRate":0.75,"avgChangeRate":0.084701},{"month":6,"riseRate":0.25,"avgChangeRate":-0.120031},{"month":7,"riseRate":0.5,"avgChangeRate":0.248957},{"month":8,"riseRate":0.75,"avgChangeRate":0.490729},{"month":9,"riseRate":0.125,"avgChangeRate":-0.110244},{"month":10,"riseRate":0.25,"avgChangeRate":-0.078244},{"month":11,"riseRate":0.25,"avgChangeRate":-0.089283},{"month":12,"riseRate":0.5,"avgChangeRate":-0.014533}],"exchange":"NASDAQ","name":"Equillium Inc.","nameEN":"Equillium Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Equillium Inc.(EQ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Equillium Inc.(EQ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Equillium Inc.,EQ,Equillium Inc.股票,Equillium Inc.股票老虎,Equillium Inc.股票老虎国际,Equillium Inc.行情,Equillium Inc.股票行情,Equillium Inc.股价,Equillium Inc.股市,Equillium Inc.股票价格,Equillium Inc.股票交易,Equillium Inc.股票购买,Equillium Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Equillium Inc.(EQ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Equillium Inc.(EQ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction